- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
- News News
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit
- Join Join
Earlier today Americans for Safe Access (ASA) submitted expanded testimony to the DC Council on Bill 21-192, the “Medical Marijuana Laboratory Testing Amendment Act of 2015" and Bill 21-210 the “Medical Marijuana Reciprocity Amendment Act of 2015.”
These bills represent important steps towards modernizing the District of Columbia’s medical marijuana program. ASA supports both bills, but is seeking improvements to B21-210 to ensure adequate supply and address technical issues. ASA also asked the Council to add delivery and civil protections to the bill.
The Medical Marijuana Laboratory Testing Amendment Act would allow DC to finally have laboratory testing by third parties. This is an essential step for patients to have the confidence they deserve in their medicine. The Medical Marijuana Reciprocity Amendment Act of 2015 is also an important reform, however with the dramatic shortages of medicine in DC’s current system allowing out of the District patients access to the dispensaries would be problematic until those shortages are addressed.
ASA is also asking the Council to move on protecting medical marijuana patients from civil discrimination. In the past few years we’ve seen genuinely tragic instances of parents losing custody of their children, workers being fired and even people being denied organ transplants for no other reason than their doctor recommend medical marijuana usage. These problems can be avoided in the District if the Council acts now instead of waiting.
Please ask your Council Member to support Bill 21-192 and Bill 21-210 with our requested changes. Click here to locate your council member.
Read our full testimony here: